期刊文献+

肺毛细血管楔压与心脏再同步化治疗慢性心衰疗效的相关性分析 被引量:4

Association between pulmonary capillary wedge pressure and clinical outcome of cardiac resynchronization therapy in chronic heart failure patients
下载PDF
导出
摘要 目的 :探讨右心导管肺毛细血管楔压(pulmonary capillary wedge pressure,PCWP)与心脏再同步化治疗(cardiac resynchronization therapy,CRT)慢性心衰疗效的相关性。方法:入选拟行心脏再同步化治疗的慢性心衰患者,术前1周内进行右心导管检查,测定肺毛细血管楔压;根据CRT术后患者心功能变化分成CRT有反应组与无反应组。术后6个月内左室射血分数(LVEF)提高超过5%,纽约心功能分级(NYHA)降低1级或1级以上者定义为CRT有反应;通过受试者工作曲线分析PCWP对CRT反应性的预测价值。应用Kaplan-Meier生存曲线分析不同水平PCWP患者主要心血管不良事件的差异。结果:35例CRT患者中有反应24例,无反应11例;有反应组PCWP(11.9±7.0)mm Hg,无反应组PCWP(21.7±9.1)mm Hg,两组间差异有统计学意义(P=0.006)。以PCWP 12.0 mm Hg为最佳分界点时,Youden指数最大,预测CRT反应性的敏感度为90.9%,特异度为58.3%。相对于PCWP>12.0 mm Hg组,PCWP≤12.0 mm Hg组CRT术后心功能、左室内径和PCWP更佳。Kaplan-Meier生存曲线表明PCWP≤12.0 mm Hg组患者比PCWP>12.0 mm Hg组患者无主要心血管不良事件的生存时间长,但未达到统计学差异(P=0.079)。结论:术前右心导管检测PCWP对CRT反应性有较好的预测价值。术前PCWP低的患者无主要心血管不良事件的生存时间长。 Objective:To investigate the association between pulmonary capillary wedge pressure(PCWP)and clinical outcome of cardiac resynchronization therapy(CRT)in chronic heart failure patients. Methods:Chronic heart failure patients with an indication for CRT were included. We performed right heart catheterization to measure PCWP in those patients one week before they received a CRT device. Patients were stratified into two groups based on their response to CRT:responders and non-responders. Responders were predefined as patients with improvement of left ventricular ejection fraction(LVEF)by 5% or more and improvement by one or more NYHA functional class during 6-month follow-up. Receiver operating characteristic(ROC)curve was used to assess the efficiency of preoperative PCWP in predicting CRT response. Kaplan-Meier survival curve was applied to assess the efficiency of preoperative PCWP in predicting major adverse cardiac events(MACE). Results:Of 35 patients included,24 patients were responders,11 patients were non-responders. The mean PCWP was(11.9 ± 7.0)mm Hg and(21.7 ± 9.1)mm Hg,respectively. Non-responders had a significantly higher PCWP(P=0.006). When at the optimal cutoff point of 12.0 mm Hg,the sensitivity and specificity of preoperative PCWP predicting response to CRT were 90.9% and 58.3%,respectively. Patients with preoperative PCWP 12.0 mm Hg or less have better NYHA functional class、smaller left ventricle and lower PCWP after CRT compared with patients with preoperative PCWP 12.0 mm Hg ormore. Kaplan Meier survival curve demonstrated that compared with patients with preoperative PCWP 12.0 mm Hg or less,patients with preoperative PCWP 12.0 mm Hg or more had a trend towards being shorter MACE-free survival(P =0.079). Conclusion:Preoperative PCWP is associated with response to CRT. Lower preoperative PCWP may indicate longer MACE-free survival time in CHF patients.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2016年第4期411-415,455,共6页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金资助(81470457)
关键词 心力衰竭 肺毛细血管楔压 PCWP 心脏再同步化治疗 右心导管术 heart failure pulmonary capillary wedge pressure PCWP cardiac resynchronization therapy right heart catheterization
  • 相关文献

参考文献23

  • 1Abraham WT, Fisher WG, Smith AL. Cardiac resynchro- nization in chronic heart failure[J]. N Engl J Med,2002,346 (24) : 1845-1853.
  • 2Moss AJ,Hall WJ,Cannom DS,et al. Cardiac-Resynchro- nization therapy for the prevention of Heart-Failure events[J]. N Engl J Med,2009,361 (14):1329-1338.
  • 3Linde C, Gold MR, Abraham WT, et al. Long-term impact of cardiac resynchronization therapy in mild heart fail- ure:5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (RE- VERSE)study[J]. Eur Heart J, 2013,34(33) : 2592-2599.
  • 4Gillis AM, Kerr CR, Philippon F,et al. Impact of cardiac resynchronization therapy on hospitalizations in the Resynchronization-Defibrillation for ambulatory heart failure trial[J]. Circulation, 2014, 129(20) : 2021-2030.
  • 5European Heart Rhythm Association (EHRA),European Society of Cardiology (ESC), Heart Rhythm Society, et al. 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure:implant and follow-up recommendations and management[J]. Eu- ropace, 2012, 14(9) : 1236-1286.
  • 6Goldenberg I, Moss A J, Hall WJ,et al. Predictors of re- sponse to cardiac resynchronization therapy in the Multi- center Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy(MADIT-CRT) [J]. Circulation,2011,124(14) : 1527-1536.
  • 7Hsu JC, Solomon SD, Bourgoun M,et al. Predictors of su- per-response to cardiac resynchronization therapy and as- sociated improvement in clinical outcome the MADIT- CRT(multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy)study[J]. J Am Coll Cardiol, 2012,59 (25) : 2366-2373.
  • 8唐园园,侯小锋,陈震,王权鹏,王垚,邹建刚.血清N-末端脑钠肽与心脏再同步化治疗慢性心衰患者预后的相关研究[J].南京医科大学学报(自然科学版),2015,35(12):1714-1717. 被引量:5
  • 9Chung ES,Leon AR,Tavazzi L,et al. Results of the pre- dictors of response to CRT(PROSPECT) trial[J]. Circu- lation, 2008,117 (20) : 2608-2616.
  • 10Chan PS, Khumri T, Chung ES, et al. Echocardiographic dyssynchrony and health status outcomes from cardiac resynchronization therapy:insights from the PROSPECT trial [J ]. JACC Cardiovasc Imaging, 2010,3 (5) : 451-460.

二级参考文献23

  • 1周秀娟,桂鸣,李拥军,戴振华,高甬东.卡维地洛对老年充血性心力衰竭患者心功能和细胞因子的影响[J].南京医科大学学报(自然科学版),2005,25(6):371-373. 被引量:2
  • 2赵思勤,李秋,吴涛,刘小蓉,赵宁,聂晓莉,王勉,胡咏梅.心力衰竭患者脑利钠肽浓度与血流动力学的关系及临床意义[J].中华心血管病杂志,2005,33(6):502-504. 被引量:40
  • 3Macintyre L, Capewell S, Steward S, et al. Evidence of improving prognosis in heart failure: trends in case fatality in 66547 patients hospitalized between 1986 and 1995. Circulation, 2000, 102: 1126-1131.
  • 4Groenning BA, Nilsson JC, Sondergard L, et al. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. Eur J Heart Fail, 2001, 3:699-708.
  • 5Betteneourt P, Ferreira A, Dias P. Predictors of prognosis in patients with stable mild to moderate heart failure. J Card Fail,2000, 6: 306-313.
  • 6Kazanegra R, Cheng V, Garcia A, et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressure in patients treated for decompensated heart failure : a pilot study. J Card Fail, 2001,7:21-29.
  • 7Cheng V, Kazanagra R, Garcia A, et al. A rapid bedside test for B-type peptides predicts treatment outcomes in patients admitted for decompensated heart failure : a pilot study. J Am Coll Cardiol, 2001, 37:386-391.
  • 8Shah MR, Stinnett SS, McNulty SE, et al. Hemodynamics as surrogate end points for survival in advanced heart failure: an analysis from FIRST. Am Heart J, 2001, 141 : 908-914.
  • 9Alehagen U, Lindstedt G, Levin LA, et al. Risk of cardiovascular death in elderly patients with possible heart failure. B-type natriuretic peptides (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6-year follow-up pf a primary care population. International .loumal of Carfiology, 2005, 100: 125-133.
  • 10Mc Donagh T, Cunningham AD, Morrison CE, et al. Left ventricular dysfunction, natriuretic peptide, and mortality in an urban population. Heart, 2001, 86: 21-26.

共引文献21

同被引文献17

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部